Xestospongin C induces monocytic differentiation of HL60 cells through activation of the ERK pathway

Food and Chemical Toxicology

Volumn 55, Issue , 2013, Pages 505-512

  Moon, Dong Oh ^a   Asami, Yukihiro ^b   Kim, Mun Ock ^b   Jang, Jae Hyuk ^b   Kim, Bo Yeon ^b   Ahn, Jong Seog ^b   Kim, Gi Young ^c   Yun, Sung Gyu ^a  

^a Daegu University   (South Korea)

^b Korea Research Institute of Bioscience and Biotechnology (KRIBB)   (South Korea)

^c Jeju National University   (South Korea)

Author keywords

Differentiation; Extracellular signal regulated kinase; HL60; Xestospongin C

Indexed keywords

CD11B ANTIGEN; CD14 ANTIGEN; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; RETINOIC ACID; TUMOR NECROSIS FACTOR ALPHA; TUMOR NECROSIS FACTOR RECEPTOR; XESTOSPONGIN C;

ANTIGEN EXPRESSION; ANTIPROLIFERATIVE ACTIVITY; ARTICLE; CANCER INHIBITION; CELL ACTIVATION; CELL DIFFERENTIATION; CELL LINEAGE; CELL PHAGOCYTOSIS; CELL PROLIFERATION; CELL STRAIN HL 60; CELL VIABILITY; CONCENTRATION RESPONSE; CONTROLLED STUDY; DRUG EFFECT; ENDOCYTOSIS; ENZYME ACTIVATION; G1 PHASE CELL CYCLE CHECKPOINT; G2 PHASE CELL CYCLE CHECKPOINT; HUMAN; HUMAN CELL; S PHASE CELL CYCLE CHECKPOINT; SIGNAL TRANSDUCTION;

ANTIGENS, CD14; CELL DIFFERENTIATION; ENZYME ACTIVATION; EXTRACELLULAR SIGNAL-REGULATED MAP KINASES; G1 PHASE; HL-60 CELLS; HUMANS; MACROCYCLIC COMPOUNDS; MONOCYTES; OXAZOLES; SIGNAL TRANSDUCTION;

EID: 84874440783     PISSN: 02786915     EISSN: 18736351     Source Type: Journal    
DOI: 10.1016/j.fct.2013.01.037     Document Type: Article

References (33)

1. 3 promotesmonocytopoiesis and suppresses granulocytopoiesis in cultures of normal human myeloid blast cells. J. Leukocyte Biol. 1994, 56:124-132.
2. Birnie G.D. The HL60 cell line: a model system for studying human myeloid cell differentiation. Br. J. Cancer 1988, 9:S41-S45.
3. 3: comparison with the maturation of normal monocytic and granulocytic bone marrow cells. J. Leukocyte Biol. 1995, 58:547-555.
4. Castonguay A., Robitaille R. Xestospongin C is a potent inhibitor of SERCA at a vertabrate synapse. Cell Calcium 2002, 32:39-47.
5. Collins S.J., Ruscetti F.W., Gallagher R.E., Gallo R.C. Normal functional characteristics of cultured human promyelocytic leukemia cells (HL-60) after induction of differentiation by dimethylsulfoxide. J. Exp. Med. 1979, 149:969-974.
6. Cros E., Jordheim L., Dumontet C., Galmarini C.M. Problems related to resistance to cytarabine in acute myeloid leukemia. Leukemia Lymphoma 2004, 45:1123-1132.
7. Depraetere S., Joniau M. Potentiation of tumor necrosis factor-mediated cytotoxicity on human myeloid cell lines: effects of interferons versus dimethyl sulphoxide. Leukemia Res. 1995, 19:803-809.
8. Depraetere S., Vanhaesebroeck B., Fiers W., Willems J., Joniau M. Polar agents with differentiation inducing capacity potentiate tumor necrosis factor-mediated cytotoxicity in human myeloid cell lines. J. Leukocyte Biol. 1995, 57:141-151.
9. 3 or all-trans-retinoic acid. Exp. Cell Res. 2001, 266:126-134.
10. Gafni J., Munsch J.A., Lam T.H., Catlin M.C., Costa L.G., Molinski T.F., Pessah I.N. Xestospongins: potent membrane permeable blockers of the inositol 1,4,5-triphosphate receptor. Neuron 1997, 19:723-733.
11. 3 involves Raf1 but not Erk 1/2 signaling. Cell Cycle 2008, 7:917-924.
12. Jing Y., Nakajo S., Xia L., Nakaya K., Fang Q., Waxman S., Han R. Boswellic acid acetate induces differentiation and apoptosis in leukemia cell lines. Leukemia Res. 1999, 23:43-50.
13. Kantarjian H., Gandhi V., Cortes J., Verstovsek S., Du M., Garcia-Manero G., Giles F., Faderl S., O'Brien S., Jeha S., Davis J., Shaked Z., Craig A., Keating M., Plunkett W., Freireich E.J. Phase 2 clinical and pharmacologic study of clofarabine in patients with refractory or relapsed acute leukemia. Blood 2003, 102:2379-2386.
14. 3, and granulocyte-macrophage colony-stimulating factor. Blood 1997, 90:4578-4587.
15. 3 - and all-trans retinoic acid-induced leukemia cell differentiation via PKCβI/MAPK pathways. Biochem. Pharmacol. 2009, 77:1694-1701.
16. Nakagawa M., Endo M. Structures of xestospongin A, B, C and D, novel vasodilative compounds from marine sponge, Xestospongia exigua. Tetrahedron Lett. 1984, 25:3227-3230.
17. Newburger P.E., Speier C., Borregaard N., Walsh C.E., Whitin J.C., Simons E.R. Development of the superoxide-generating system during differentiation of the HL-60 human promyelocytic leukemia cell line. J. Biol. Chem. 1984, 259:3771-3776.
18. Oesch F., Schäfer A., Wieser R.J. 12-O-tetradecanoylphorbol-13-acetate releases human diploid fibroblasts from contact-dependent inhibition of growth. Carcinogenesis 1988, 9:1319-1322.
19. Renzi D., Valtolina M., Foster R. The evaluation of a multi-endpoint cytotoxicity assay system. ATLA 1993, 21:89-96.
20. 2+]i-increasing agents cyclopiazonic acid and thapsigargin. J. Biol. Chem. 1994, 269:8786-8791.
21. Soundararajan R., Prabha P., Rai U., Dixit A. Antileukemic potential of Momordica charantia seed extracts on human myeloid leukemic HL60 cells. Evid. Based Complement. Alternat. Med. 2012, 2012:732404.
22. Stone R.M. Novel therapeutic agents in acute myeloid leukemia. Exp. Hematol. 2007, 35:163-166.
23. Studzinski G.P., Wang X., Ji Y., Wang Q., Zhang Y., Kutner A., Harrison J.S. The rationale for deltanoids in therapy for myeloid leukemia: role of KSR-MAPK-C/EBP pathway. J. Steroid Biochem. Mol. Biol. 2005, 97:47-55.
24. Tallmann M.S. Curative therapeutic approaches to APL. Ann. Hematol. 2004, 83:S81-S82.
25. Therrien M., Chang H.C., Solomon N.M., Karim F.D., Wassarman D.A., Rubin G.M. KSR, a novel protein kinase required for RAS signal transduction. Cell 1995, 83:879-888.
26. Therrien M., Michaud N.R., Rubin G.M., Morrison D.K. KSR modulates signal propagation within the MAPK cascade. Genes Dev. 1996, 10:2684-2695.
27. 2+-ATPases. Trends Pharmacol. Sci. 1998, 19:131-135.
28. Wald D.N., Vermaat H.M., Zang S., Lavik A., Kang Z., Peleg G., Gerson S.L., Bunting K.D., Agarwal M.L., Roth B.L., Tse W. Identification of 6-benzylthioinosine as a myeloid leukemia differentiation-inducing compound. Cancer Res. 2008, 68:4369-4376.
29. 3 and the effect of interferon γ. J. Leukocyte Biol. 1993, 54:40-46.
30. Wen C.L., Teng C.L., Chiang C.H., Chang C.C., Hwang W.L., Kuo C.L., Hsu S.L. Methanol extract of Antrodia cinnamomea mycelia induces phenotypic and functional differentiation of HL60 into monocyte-like cells via an ERK/CEBP-β signaling pathway. Phytomedicine 2012, 19:424-435.
31. Yam L.T., Li C.Y., Crosby W.H. Cytochemical identification of monocytes and granulocytes. Am. J. Clin. Pathol. 1971, 55:283-290.
32. You A. Differentiation, apoptosis and function of human immature and mature myeloid cells: intracellular signaling mechanism. Int. J. Hematol. 2001, 73:438-452.
33. Zhang T., He Y.M., Wang J.S., Shen J., Xing Y.Y., Xi T. Ursolic acid induces HL60 monocytic differentiation and upregulates C/EBPβ expression by ERK pathway activation. Anticancer Drugs 2011, 22:158-165.